21
Oct 16 (Reuters) – KEXING BIOPHARM: * KEXING BIOPHARM: CO'S BIOLOGICS LICENSE APPLICATION FOR LONG-ACTING G-CSF CANDIDATE GB-K02 ACCEPTED FOR REVIEW Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
First published on: Oct 16, 2026 8:08 PM IST
——————————————–
————————————————–
Stay informed on all the latest news, breaking news updates, and check all the important headlines in India news, World News, Sports News and Entertainment News on NewsX. Follow Us on Facebook, Twitter.
You Might Be Interested In